Goldstein M - Search Results

1

Biochemical analysis of caudate nucleus biopsy samples from parkinsonian patients.

Goldstein M, Lieberman AN, Helmer E, Koslow M, Ransohoff J, Elsworth JD, Roth RH, Deutch AY. Goldstein M, et al. Ann Neurol. 1988 Nov;24(5):685-8. doi: 10.1002/ana.410240517. Ann Neurol. 1988. PMID: 2904793

2

The role of the regulatory enzymes of catecholamine synthesis in Parkinson's disease.

Goldstein M, Lieberman A. Goldstein M, et al. Neurology. 1992 Apr;42(4 Suppl 4):8-12; discussion 41-8. Neurology. 1992. PMID: 1350074 Review.

3

Adrenal medullary transplants as a treatment for Parkinson's disease.

Lieberman A, Ransohoff J, Berczeller P, Brous P, Eng K, Goldstein M, Kaufman B, Koslow M, Lieberman I. Lieberman A, et al. Among authors: goldstein m. Adv Neurol. 1990;53:567-70. Adv Neurol. 1990. PMID: 2239497 No abstract available.

4

3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: an animal model of olivopontocerebellar atrophy-associated parkinsonism.

Deutch AY, Rosin DL, Goldstein M, Roth RH. Deutch AY, et al. Among authors: goldstein m. Exp Neurol. 1989 Jul;105(1):1-9. doi: 10.1016/0014-4886(89)90166-0. Exp Neurol. 1989. PMID: 2568269

5

Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.

Rosin DL, Clark WA, Goldstein M, Roth RH, Deutch AY. Rosin DL, et al. Among authors: goldstein m. Neuroscience. 1992 Jun;48(4):831-9. doi: 10.1016/0306-4522(92)90271-3. Neuroscience. 1992. PMID: 1352864

6

The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes.

Goldstein M, Lieberman AN, Takasugi N, Shimizu Y, Kuga S. Goldstein M, et al. Adv Neurol. 1990;53:101-6. Adv Neurol. 1990. PMID: 1978511 Review. No abstract available.

7

Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.

Lieberman AN, Gopinathan G, Pasternack P, Goldstein M. Lieberman AN, et al. Among authors: goldstein m. Adv Neurol. 1990;53:533-7. Adv Neurol. 1990. PMID: 1978521 Clinical Trial. No abstract available.

8

3-Acetylpyridine results in degeneration of the extrapyramidal and cerebellar motor systems: loss of the dorsolateral striatal dopamine innervation.

Deutch AY, Elsworth JD, Roth RH, Goldstein M. Deutch AY, et al. Among authors: goldstein m. Brain Res. 1990 Sep 10;527(1):96-102. doi: 10.1016/0006-8993(90)91065-o. Brain Res. 1990. PMID: 2126479 Free article.

9

Adrenal medullary transplants as a treatment for advanced Parkinson's disease.

Lieberman A, Ransohoff J, Berczeller P, Goldstein M. Lieberman A, et al. Among authors: goldstein m. Prog Brain Res. 1990;82:665-9. doi: 10.1016/s0079-6123(08)62657-6. Prog Brain Res. 1990. PMID: 2290968 No abstract available.

10

Antibodies to a synthetic peptide corresponding to a Ser-40-containing segment of tyrosine hydroxylase: activation and immunohistochemical localization of tyrosine hydroxylase.

Lee KY, Lew JY, Tang D, Schlesinger DH, Deutch AY, Goldstein M. Lee KY, et al. Among authors: goldstein m. J Neurochem. 1989 Oct;53(4):1238-44. doi: 10.1111/j.1471-4159.1989.tb07420.x. J Neurochem. 1989. PMID: 2570128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,640 results

Search Page

Filters